ACC pushes exercise into the center of cardiovascular treatment
A new scientific statement from the American College of Cardiology argues that exercise should be treated like a standard part of cardiovascular care, not an optional add-on. Published in the Journal of the American College of Cardiology, the guidance places regular physical activity and improved cardiorespiratory fitness alongside medications, procedures, and risk-factor control in the prevention and treatment of heart disease.
The clinical logic is straightforward. Low fitness is not just a marker of deconditioning; it predicts future cardiovascular disease risk at a level comparable to smoking, hypertension, high cholesterol, and diabetes. In other words, the ability to deliver oxygen during sustained activity has real prognostic weight, and it belongs in the same risk conversation as the factors clinicians already track every day.
One sentence in the statement carries especially direct bedside meaning: even modest movement can matter.
That matters because many patients never reach the idealized image of exercise that tends to dominate public messaging. The ACC guidance makes room for a more realistic starting point, especially for people who are sedentary, symptomatic, older, or recovering from cardiac illness.
Modest activity gains can still move risk in the right direction
The statement points to evidence that around 5,000 to 7,000 daily steps are associated with clinically important benefits. For many adults, that range is linked to meaningful reductions in cardiovascular and all-cause mortality, without requiring the often-cited 10,000-step target. The practical implication is immediate: clinicians do not need to wait for a patient to become an athlete before they can expect benefit.
Physiologically, the value of regular movement is not mysterious. Aerobic activity improves oxygen delivery and utilization, while resistance training supports muscle strength and functional reserve. Together, these adaptations can reduce exertional symptoms, increase exercise tolerance, and improve the day-to-day capacity that determines whether a patient can climb stairs, carry groceries, or participate in cardiac rehabilitation.
The statement also emphasizes that exercise can reduce hospitalizations and improve quality of life. Those outcomes matter because cardiovascular care is not judged only by long-term survival curves; it is also measured by how often patients decompensate, how well they function between visits, and whether treatment leaves them more independent or more limited.
Exercise prescriptions should be individualized, not generic
The ACC statement is explicit that exercise advice must be tailored to the person in front of the clinician. Functional capacity, symptoms, cardiovascular condition, treatment goals, and patient preferences should shape the prescription. A one-size-fits-all directive to “exercise more” is too blunt for a field that routinely individualizes medications down to dose, timing, and drug class.
Jonathan Myers, PhD, who chaired the writing committee, argued that exercise should be viewed as a fundamental part of cardiovascular health care. His critique of current practice is familiar to anyone who works in clinic: clinicians are trained extensively in medications and procedures, but far less in how to prescribe physical activity in a structured, safe way.
He also drew a practical contrast between vague encouragement and real prescribing. Telling patients to get more exercise is not enough. Specific recommendations on frequency, intensity, and progression are far more useful, especially when anxiety, pain, heart failure symptoms, ischemia concerns, or post-procedural recovery complicate the picture.
The statement’s approach is also grounded in safety. Routine exercise testing is not necessary for most asymptomatic or clinically stable people before they become more active. Testing becomes more relevant when clinicians need to define a safe starting point, assess capacity, or evaluate a person with known cardiovascular disease or symptoms. For patients with active myocarditis, unstable cardiac symptoms, or certain cardiomyopathies, exercise limits and specialized assessment may be necessary.
Cardiac rehabilitation remains the clearest path for many patients
Cardiac rehabilitation sits at the center of the ACC statement as a first-line intervention for many people with established cardiovascular disease. Its value comes from structure. Patients receive supervised exercise along with broader support that can include education, monitoring, and behavioral coaching, all of which help translate physiologic benefit into sustained functional gains.
Access remains a major obstacle. Insurance reimbursement, limited availability, and practical barriers keep many patients from entering or completing formal programs. When rehabilitation is unavailable, the statement supports individualized exercise prescriptions as a fallback strategy rather than leaving patients without direction.
Home-based and virtual approaches also have a role, especially when transportation, schedule constraints, or geographic distance make traditional rehabilitation unrealistic. Wearables and digital tools may help patients track activity and stay engaged, although adherence over time remains a persistent challenge.
Why cardiovascular care still underuses exercise
The gap between evidence and routine practice is not due to uncertainty about whether activity helps. It reflects training, time, and system design. Short appointments push exercise counseling aside, reimbursement is limited, and many clinicians lack formal education in prescribing physical activity for patients with complex cardiovascular disease.
There is also a cultural problem in medicine. Blood pressure, cholesterol, diabetes, and smoking are treated as routine targets because clinicians have clear frameworks for addressing them. Exercise often gets framed as advice instead of treatment, even though its biologic effect on fitness, symptoms, and long-term risk can be substantial.
Myers said the field needs to assess physical activity and physical fitness as routinely as other cardiovascular risk factors. The statement’s practical aim is to make exercise counseling as normal as ordering labs or adjusting antihypertensive therapy.
Small first steps may be enough to begin
For people who are currently inactive, the guidance favors achievable movement over intimidating goals. A 10-minute walk each day, especially after a meal, can be a realistic starting point. Short bouts of movement, stair climbing when feasible, walking while on the phone, and breaking up long periods of sitting can all add up.
This is where bedside counseling can become more clinically useful than a generic wellness message. A patient with heart disease does not need a perfect plan to begin benefiting from movement. They need an activity they can tolerate, a pace they can maintain, and enough follow-up to adjust the plan as symptoms, confidence, and capacity change.
The statement also calls for broader research into how to improve long-term adherence. That question remains central, because the short-term physiology of exercise is clear while the challenge of sustaining it in real life is not. Without better systems for referral, follow-up, and access, the strongest exercise advice will continue to reach only part of the population that could benefit from it.